Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hepatitis

  Free Subscription


19.08.2019

1 Ann Intern Med
1 Arch Virol
2 Clin Infect Dis
1 Dig Dis Sci
2 Gastroenterology
2 Hepatology
1 J Hepatol
1 J Infect Dis
1 J Med Virol
2 J Viral Hepat
3 Transplant Proc
1 Vaccine
1 Z Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Intern Med

  1. DURAND CM, Bowring MG, Thomas AG, Kucirka LM, et al
    The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States: A National Registry Study.
    Ann Intern Med. 2018 Apr 17. pii: 2678899. doi: 10.7326/M17-2451.
    PubMed     Text format     Abstract available


    Arch Virol

  2. PONDE RAA
    Expression and detection of anti-HBs antibodies after hepatitis B virus infection or vaccination in the context of protective immunity.
    Arch Virol. 2019 Aug 9. pii: 10.1007/s00705-019-04369.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  3. PEAK CM, Stous SS, Healy JM, Hofmeister MG, et al
    Homelessness and Hepatitis A - San Diego County, 2016-2018.
    Clin Infect Dis. 2019 Aug 15. pii: 5550168. doi: 10.1093.
    PubMed     Text format     Abstract available

  4. STEVENS ER, Nucifora KA, Hagan H, Jordan AE, et al
    Cost-effectiveness of direct anti-viral agents for hepatitis C virus infection and a combined intervention of syringe access and medication assisted therapy for opioid use disorders in an injection drug use population.
    Clin Infect Dis. 2019 Aug 11. pii: 5546014. doi: 10.1093.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  5. ALI RO, Moon MS, Townsend EC, Hill K, et al
    Exploring the Link Between Platelet Numbers and Vascular Homeostasis Across Early and Late Stages of Fibrosis in Hepatitis C.
    Dig Dis Sci. 2019 Aug 12. pii: 10.1007/s10620-019-05760.
    PubMed     Text format     Abstract available


    Gastroenterology

  6. LOK AS, Sulkowski MS, Kort JJ, Willner I, et al
    Efficacy of Glecaprevir and Pibrentasvir in Patients with Genotype 1 Hepatitis C Virus Infection with Treatment Failure after NS5A Inhibitor Plus Sofosbuvir Therapy.
    Gastroenterology. 2019 Aug 8. pii: S0016-5085(19)41199.
    PubMed     Text format     Abstract available

  7. GAL-TANAMY M
    Multi-omic Analyses Reveal Complex Interactions Between HCV and Hepatocytes Demonstrating That the Red Queen Is Up and Running.
    Gastroenterology. 2019;157:300-302.
    PubMed     Text format    


    Hepatology

  8. PATRA T, Meyer K, Ray RB, Ray R, et al
    Hepatitis C virus mediated inhibition of miR-181c activates ATM signaling and promotes hepatocyte growth.
    Hepatology. 2019 Aug 10. doi: 10.1002/hep.30893.
    PubMed     Text format     Abstract available

  9. ATCHESON E, Li W, Bliss CM, Chinnakannan S, et al
    Use of an outbred rat hepacivirus challenge model for design and evaluation of efficacy of different immunisation strategies for HCV.
    Hepatology. 2019 Aug 10. doi: 10.1002/hep.30894.
    PubMed     Text format     Abstract available


    J Hepatol

  10. CHILDS K, Davis C, Cannon M, Montague S, et al
    Suboptimal SVR rates in African patients with atypical Genotype 1 subtypes: implications for global elimination of Hepatitis C.
    J Hepatol. 2019 Aug 7. pii: S0168-8278(19)30468.
    PubMed     Text format     Abstract available


    J Infect Dis

  11. CHOI YH, Perez-Cuevas MB, Kodani M, Zhang X, et al
    Feasibility of Hepatitis B Vaccination by Microneedle Patch: Cellular and Humoral Immunity Studies in Rhesus Macaques.
    J Infect Dis. 2019 Aug 13. pii: 5549399. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  12. XU J, Tao LL, Ma LX
    Efficacy and safety of telbivudine to prevent mother-to-child transmission of hepatitis B virus in middle and late stage pregnancy with high viral loads.
    J Med Virol. 2019 Aug 9. doi: 10.1002/jmv.25566.
    PubMed     Text format     Abstract available


    J Viral Hepat

  13. FUJII H, Enomoto M, Murakami Y, Hagihara A, et al
    Last crusade against HCV: Direct-acting antiviral treatment for marginalized populations.
    J Viral Hepat. 2019 Aug 14. doi: 10.1111/jvh.13190.
    PubMed     Text format     Abstract available

  14. YIN X
    It is too early to evaluate mother-to-child transmission of hepatitis B within 24 hours after delivery.
    J Viral Hepat. 2019 Aug 14. doi: 10.1111/jvh.13189.
    PubMed     Text format     Abstract available


    Transplant Proc

  15. SERIN A, Tokat Y
    Recurrence of Hepatitis D Virus in Liver Transplant Recipients With Hepatitis B and D Virus-Related Chronic Liver Disease.
    Transplant Proc. 2019 Aug 9. pii: S0041-1345(18)31750.
    PubMed     Text format     Abstract available

  16. SERIN A, Sahin T, Emek E, Arikan T, et al
    Role of Preoperative Viral Load and Presence of Hepatocellular Carcinoma in the Biliary Complications After Liver Transplantation Due to Hepatitis C Virus.
    Transplant Proc. 2019 Aug 9. pii: S0041-1345(19)30242.
    PubMed     Text format     Abstract available

  17. SAHIN T, Serin A, Emek E, Bozkurt B, et al
    Effectiveness of Noninvasive Fibrosis Markers for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B and Chronic Hepatitis B+D Induced Cirrhosis.
    Transplant Proc. 2019 Aug 8. pii: S0041-1345(18)31711.
    PubMed     Text format     Abstract available


    Vaccine

  18. LEIDNER AJ, Murthy N, Chesson HW, Biggerstaff M, et al
    Cost-effectiveness of adult vaccinations: A systematic review.
    Vaccine. 2018 Dec 4. pii: S0264-410X(18)31581.
    PubMed     Text format     Abstract available


    Z Gastroenterol

  19. HUESING-KABAR A, Dohna CZ, Heinzow H, Cicinnati VR, et al
    Risk factors for allograft failure in liver transplant recipients.
    Z Gastroenterol. 2018 Jan 16. doi: 10.1055/s-0043-125225.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: